<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110948">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01899365</url>
  </required_header>
  <id_info>
    <org_study_id>12-09</org_study_id>
    <secondary_id>2013-A00943-42</secondary_id>
    <nct_id>NCT01899365</nct_id>
  </id_info>
  <brief_title>An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department</brief_title>
  <acronym>IMPROVED</acronym>
  <official_title>An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department; A Multicenter Prospective Randomized Open Trial The IMPROVED Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Princesse Grace</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Scientifique de Monaco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Princesse Grace</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>Monaco : Comité Consultatif d'Ethique en Matière de Recherche Biomédicale</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background :

      Community-acquired pneumonia (CAP) is a threat in industrialized countries. It represents
      the 6th cause of death. CAP also frequently associates with other disorders responsible for
      admission and death. Among bacteria responsible for CAP, Streptococcus pneumonia is a major
      pathogen that is commonly involved and frequently leads to severe infection and admission.
      Categories at risk for this pathogen have been determined, and can be proposed
      anti-pneumococcal vaccination (APV) that efficiently and safely protects from this
      microorganism.

      In the context of US health services, monocenter pilot experiences have reported improvement
      of pneumococcal prophylaxis implementing vaccination procedure at ED. A study that set in
      New Mexico (2003) reported a significant increase in APV (from 18% to 84%) when patients at
      risk were proposed vaccination at ED. To obtain these results, medical students were
      specifically trained and dedicated to screen and vaccinate against St. pneumoniae. Another
      single center trial (Tennessee, 2007) for APV at ED obtained an improvement (from 38.8 to
      45.4%) when physicians were alerted for pneumococcal risk by the software they usually
      utilized at bedside. However these experiences remain sparse as additional dedicated
      resources are required or patients and attending ED physicians can be reluctant to proceed
      to vaccination at ED.

      Mobile phone and derived communication modalities are current vectors to deliver information
      in several fields including education and medicine. Initially used in developing countries,
      short-message services (SMS) have improved behaviour of patients in various medical areas.
      In France, the investigators have observed that most patients above 50 years of age admitted
      after ED visit are equipped with mobile phone and can receive alerts by SMS.

      These observations prompt us to propose a multifaceted procedure to improve APV after ED
      visit in at-risk patients, combining structured oral interview, written information and SMS
      as reminders.

      Purpose : The investigators hypothesized that

        -  a multifaceted intervention to promote anti-pneumococcal vaccination combining a
           structured oral interview, a written information to patient and his/her general
           practitioner, and a series of 3 SMS,

        -  improves anti-pneumococcal vaccination at 6 months,

        -  in at-risk patients (65+ years) visiting the emergency department. In order to answer
           this question, the investigators designed an interventional prospective multicenter
           randomized study (cluster).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Impact of a multifaceted procedure at ED visit on anti-pneumococcal vaccination. (APV) at 6-month. Evaluation criteria : Δ percentage (%) of APV vaccination at 6-month</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>On Flu vaccination at 6-month Δ percentage (%)</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>number of patients receiving vaccination against flu at 6-month. This issue will be collected by phone (patient, relative or general practioner). This will be a declarative data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>On episodes of respiratory tract infections requiring antibiotics or admission at 6-month Δ (absolute number of events)</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>number of patients who experienced respiratiory tract infection requiring antibiotics or admission. This issue will be collected by phone at 6-month (patient, relative or general practioner). This will be a declarative data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>On death at 6- and 12-month (absolute number of events)</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>On death related to infection at 6- and 12-month (absolute number of events)</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial evaluation of patients and acceptance / refusal of vaccination</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>The patient will fil a Psychosocial evaluation questionnaire during the ED visit. To achieve this issue, we will use the socio-economic indicators mobilized in investigations in social epidemiology: sex, age, education, occupation, housing, income and household size. This composite questionnaire will be used for qualitative analysis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>Pneumococcal Infections</condition>
  <arm_group>
    <arm_group_label>Multifaceted</arm_group_label>
    <description>brief structured interview with the physician about pneumococcal risk and vaccination,
information sheet delivered to patients with explanation about risk and benefit of APV,
letter given to patient for his/her general practitioner stating that the patient is at-risk for pneumococcal infection and could benefit of APV,
3 SMS every 2 weeks to remind patients talking of pneumococcal risk with general practitioner.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>information sheet delivered to patients with explanation about the aim of the study,
brief interview with the physician about study.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patient aged 65 years or over who is not vaccinated against pneumoccocus virus during
        consultation with medical emergencies
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients 65-year old and above,

          -  benefit from French or Monaco social security a social security.

        Exclusion Criteria:

          -  refuse to participate,

          -  no possibility to receive SMS,

          -  impaired cognitive functions and mental status precluding understanding of the study,

          -  anticipated barriers precluding adequate follow-up (ex. homeless),

          -  previous APV,

          -  contraindication to APV,

          -  do not understand/read French.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yann-Erick CLAESSENS, PU-PH</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Princesse Grace</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier DUVAL, PU-PH</last_name>
    <role>Study Director</role>
    <affiliation>Groupe Hospitalier Bichat Claude-Bernard</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José LABARERE, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jocelyn RAUDE, PhD</last_name>
    <role>Study Director</role>
    <affiliation>EHESP School of Public Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yann-Erick CLAESSENS, PU-PH</last_name>
    <phone>+377 97 98 39 69</phone>
    <email>yann-erick.claessens@chpg.mc</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Clermont-Ferrand</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jeannot SCHMIDT, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Jeannot SCHMIDT, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Paul Ardier</name>
      <address>
        <city>Issoire</city>
        <zip>63503</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laure JAINSKY, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Laure JAINSKY, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HM - La Conception</name>
      <address>
        <city>Marseille</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre MICHELET, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Pierre MICHELET, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HM - La Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre MICHELET, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Pierre MICHELET, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier La Palmosa</name>
      <address>
        <city>Menton</city>
        <zip>06507</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Véronique MATTEI, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Véronique MATTEI, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacques LEVRAUT, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Jacques LEVRAUT, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Louis Giorgi</name>
      <address>
        <city>Orange</city>
        <zip>84106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guillaume DER SAHAKIAN, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Guillaume DER SAHAKIAN, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick PLAISANCE, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Patrick PLAISANCE, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand RENAUD, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Bertrand RENAUD, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick RAY, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Patrick RAY, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat-Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe CHOQUET, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Christophe CHOQUET, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre HAUSFATER, PU-PH</last_name>
    </contact>
    <investigator>
      <last_name>Pierre HAUSFATER, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Saint-Denis</name>
      <address>
        <city>Saint-denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoit DOUMENC, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Benoit DOUMENC, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier intercommunal de Toulon - La Seyne sur mer</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent CARRET, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Vincent CARRET, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Vaison-la-Romaine</name>
      <address>
        <city>Vaison-la-romaine</city>
        <zip>84110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guillaume DER SAHAKIAN, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Guillaume DER SAHAKIAN, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Jules Niel</name>
      <address>
        <city>Valreas</city>
        <zip>84600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Jacques Lacarin</name>
      <address>
        <city>Vichy</city>
        <zip>03207</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Didier STORME, Doctor</last_name>
    </contact>
    <investigator>
      <last_name>Didier STORME, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Princesse Grace</name>
      <address>
        <city>Monaco</city>
        <zip>98000</zip>
        <country>Monaco</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas RIJO, ARC</last_name>
      <phone>37797988445</phone>
      <email>recherche.clinique@chpg.mc</email>
    </contact>
    <investigator>
      <last_name>Yann-Erick CLAESSENS, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Monaco</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 6, 2013</lastchanged_date>
  <firstreceived_date>July 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anti-pneumococcal vaccination</keyword>
  <keyword>information</keyword>
  <keyword>emergency department</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Pneumococcal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
